NASDAQ · Healthcare · Biotechnology
Crescent Biopharma, Inc.
CBIO
Crescent Biopharma, Inc. CEO Joshua T. Brumm · Market cap $434.8M.
$15.77
-0.61 · -3.72%
52w hi $27.4152w lo $8.72
Off 52w high 45.1%
73
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
Strong Buy
Avg PT $33.00
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jul 16 | Fairmount Funds Management LLC | Buy | 853,450 | $14.50 | +$12.38M | 73 | |
| Dec 04 | Fairmount Funds Management LLC | Buy | 1,360,000 | $13.41 | +$18.24M | 62 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug